Clinical Trial Update: C.Difficile Observational Study

View source ↗

Summary

AstraZeneca-sponsored observational study on Clostridioides difficile infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Snippet

Sponsor: AstraZeneca | Conditions: Clostridium Infections | Status: COMPLETED